Directory · PT
Biotechnology Research in Portugal
A register of firms and the professionals working at them in the Biotechnology Research sector based in Portugal. Browse the public index, then filter or export on Kipplo.
Companies
170 on file
Biosurfit
biosurfit is a european diagnostics and biotechnology company focused on the development, manufacture, and distribution of IVD tests for the point-of-care market with highly innovative proprietary technology and dedicated to provide comprehensive contract development and manufacturing services. biosurfit developed the spinit® technology, the first and only, diagnostics system capable of performing the major PoC blood test modalities (haematology, immunoassays and clinical chemistry) on the same instrument. The spinit® platform, integrates multiple diagnostic tests into a single device, delivering rapid and accurate results for healthcare professionals. Committed to improving patient outcomes, we combine cutting-edge research with practical applications to offer reliable, efficient, and user-friendly point-of-care diagnostic solutions. We want health providers to have all the necessary information to make the best possible diagnostic and treatment decision when they are with their patients. We are specialized in providing contract development and manufacturing services, leveraging our extensive portfolio of patents and expertise in microfluidics. Our commitment to innovation and excellence makes biosurfit a trusted partner for companies seeking advanced, turnkey manufacturing solutions in the healthcare industry.
51 to 200 staff
Fairjourney Biologics
At FairJourney Bio, we specialize in cutting-edge antibody discovery and development, offering end-to-end solutions that fast-track your research. With over a decade of expertise, our innovative technologies and seasoned team have successfully advanced 19 antibodies to clinical stages. Our adaptable partnership model empowers projects of any scale, fostering collaboration and breakthrough innovation. Whether you're in early-stage research or development, we deliver tailored, high-quality antibodies designed to meet your specific needs. Join us in revolutionizing therapeutic discovery and making lasting impacts on global healthcare.
201 to 500 staff
Stab Vida
Our mission is to be “your easy genetics laboratory”. Whether you are in Lisbon, Porto, Milano, Rio de Janeiro, Madrid, Cordoba, etc, we want to create an easily crossable bridge with you (a patient, a doctor, a scientist, a veterinary professional or a student), on which data and information may flow easily, supported by solid laboratories and staff from STAB VIDA to provide you with the results you need. If the last few decades were characterized by the emergence of information and telecommunication technologies, the 21st century will be remarked by the advances in gene technology. The growth of gene technology is creating platforms for new products and markets. The genetic testing market utilises genomic sequences for diagnosis and treatment of diseases and other genetic characteristics. Its high business potential has prompted governments to consider research in genomics and proteomics a strategic priority. This is the challenging environment where STAB VIDA operates and intends to enhance its performance by exploring new opportunities. In a more broader sense, our mission consists of harnessing innovation and adopting new technologies in biotechnology through research and development, technology transfer, and proper commercialization of products and services in the global market.
11 to 50 staff
Crioestaminal
Fundada em 2003, a Crioestaminal é pioneira e líder em Portugal na criopreservação de células estaminais do sangue e do tecido do cordão umbilical. Atualmente, a Crioestaminal incorpora o maior grupo Europeu na área das Células Estaminais, o Grupo Famicord, que conta com a confiança de mais de mil famílias e são já + de 3400 amostras de células estaminais utilizadas em tratamentos, 19 das quais libertadas pela Crioestaminal. A participar no piloto da semana de 4 dias. A Crioestaminal foi distinguida com Prémio Cinco Estrelas e com o prémio Escolha do Consumidor O primeiro transplante de células estaminais em Portugal deu-se em 2007 com uma amostra guardada na Crioestaminal. Desde este primeiro transplante de células estaminais, mais 9 crianças portuguesas foram já tratadas com as suas células estaminais guardadas na Crioestaminal. A Crioestaminal é o banco familiar com mais transplantes realizados, com acreditação internacional e com os serviços mais avançados, sendo também o único laboratório europeu com acreditação pela AABB (Association for the Advancement of Blood & Biotherapies), quer para o processamento de sangue quer de tecido do cordão umbilical. Conheça os nossos serviços com vantagens únicas para as Famílias Portuguesas.
51 to 200 staff
Inokem Group S.A
Somos a mais revolucionária empresa de detergentes BIO na Europa! Inventámos os detergentes ultra-concentrados que permitem poupanças massivas de plástico e de CO2 no transporte, ao mesmo tempo que garantimos produtos de eficácia profissional e a um custo pronto a utilizar sem concorrência. Os detergentes BIO da INOKEM mudaram o paradigma do mercado Europeu.
201 to 500 staff
Ilof
iLoF is a digital health company pioneering a breakthrough AI-platform to accelerate the future of personalized drug discovery and development. Through advanced AI and Photonics, iLoF is collecting massive amounts of data to build a digital library of biomarkers and biological profiles, bringing together world-class physicists, biologists, and data scientists to get life-saving personalized treatments to patients faster. Recognized by CB Insights as one of the top Digital Health companies in the world and by the Financial Times as a Transformational Business in Healthcare, iLoF is supported by leading institutions like Microsoft Ventures, Mayfield or the Oxford University, and has been regularly featured by outlets like Tech Crunch, Wired, or Sifted as a rising star in AI-Driven Drug Discovery, Health Screening & Data Analytics.
51 to 200 staff
Asfertglobal
Our main focus is the development of Biostimulants, Biocontrol and Biofertilizers, based on the use of microorganisms and new organic molecules from natural sources. We are working in more than 30 countries which include Spain, France, Greece, Turkey and Mexico.
11 to 50 staff
Entogreen
EntoGreen is an Ingredient Odyssey SA brand dedicated to the recovery of vegetable by-products through its use in black soldier fly (Hermetia illucens) as a bioconversion tool, creating novel nutrition solutions for both animals and plants
11 to 50 staff
Technophage, Sa
Launched in 2005, TechnoPhage is an innovative biopharmaceutical company committed to the R&D of new biological molecules in several therapeutic areas, such as infection, neuroscience, and ophthalmology. TechnoPhage’s strategy is based on developing new therapeutics from early discovery to clinical development, including in-house capacity for process development, and GMP production. The company has recently launched its own GMP manufacturing plant specialized in the production of biologics such as bacteriophages and antibody fragments. TechnoPhage is focused on increasing its pipeline of proprietary technologies and deriving products. This is achieved through an active R&D program and collaboration agreements with national and international pharmaceutical companies, research centers and universities across Europe, USA, and Asia. The company’s headquarters are located in Lisbon, in close proximity to the renowned Santa Maria Hospital and the Instituto de Medicina Molecular João Lobo Antunes. Overall, the proximity to these valuable partners ensures the access to the necessary equipment, and to the know-how required to develop full product solutions, including direct collaboration with leading experts from the clinical fields covering the therapeutic products under development.
11 to 50 staff
Byspectra
BySpectra is a Nano-technology company. We develop Biotechnology devices for scientific purposes, Veterinary & Healthcare.
11 to 50 staff
Immunethep
Immunethep is a biotech startup company that is developing anti-bacterial immunotherapies based on the discovery of a virulence mechanism shared by different bacteria that cause life-threatening infections. We are working on preventing and treating infectious diseases to improve global health (SDG#3) for a safer tomorrow free of AntiMicrobial Resistance (AMR). We will accomplish our mission by developing anti-infective immunotherapies that potentiate a natural and strong immune response from the infected host, reducing the disease burden and mortality rates.
11 to 50 staff
Ngc
At NGC we want to reinvent entire industries. We think beyond the product itself. Using bioscience we create greener ways of production and new product applications. OUR DRIVE There isn’t a system more perfect than Nature; it creates, recreates and adapts itself, therein lies our Vision to answer modern problems: creating models, mimicking Nature, perfecting them, and making them available at an industrial level. By doing this, our main goal is to create sustainable and efficient products and processes that incur less impact on our Planet. WE ARE REALLY CHANGING THE WORLD Today we know that the economic models upon which business’s were based are inadequate, and we find ourselves with greater inequality and less tolerance. Our planet is at risk, but at NGC we have the Capability and Business Models to make a change. We bring to market the applied knowledge of our daily practices, building less impactful and better products, making them economically viable and pushing forward the boundaries of industry. NGC creates integrated solutions with added value bringing new concepts to traditional practices to all industry segments. Our mail goal is to reinvent the way industries operate. NGC thinks beyond the product itself using bioscience to create greener ways of production and new product applications. We challenge leading companies in their industries to reinvent their products with new applicabilities, with more efficiently & less environmental impact product.processes. More than an R&D Lab, our drive is to think about new industrial concepts and add existing biochemical technologies & bioscience to create new and innovate solutions to different industries and markets. NGC - New Generation Chemistry The Concept Chemistry Company
11 to 50 staff
A4f-Algae For Future
A4F is a biotechnology company, located in Portugal, with more than 20 years of accumulated experience in algae Research & Development and algae production (up to industrial scale). A4F is specialized in the design, build, operation and transfer (DBOT) of algae production units, from research, demonstration to industrial scale, using different technologies that better adapt to our Customers’ business. Complementing our long experience, A4F distinguishes itself through its methodology which includes scaling-up from prototypes in our Experimental Unit in Lisbon to large-scale facilities. Additionally, A4F also develops standard operating procedures for optimized algae production, according to production goals and with industry best practices. A4F has a very close relationship with the leading research groups in national and international universities and institutes in algae biotechnology (and related R&D fields), as well as with the largest algae producers worldwide. A4F, the first choice for any large-scale contract as a specialist in algae production.
11 to 50 staff
Biotrend Sa
Biotrend carries out research and develops in-house projects aiming at the production of bio-based chemicals, materials and fuels from renewable raw materials. We cover process development aspects from strain screening to fermentation optimization, process integration, intensification, de-risking and scale-up using our in-house capabilities between 1mL to 250L fermentation capacity and helping the transition to demo and commercial scale through our network of partners. At Biotrend we put our know-how and resources to the service of our clients by providing contract research and development services and we develop in-house research programs to develop new technologies to be licensed out to industrial clients. Further, we participate in international collaborative projects encompassing the full bioeconomy value chain, keeping Biotrend at the forefront of scientific development.
11 to 50 staff
Genetyca Icm S.A
At GENETYCA ICM Portugal we have the mission to offer you the most advanced technologies and laboratory methods worldwide. We accompany and challenge science to give you the best it has to offer. Our commitment is to be by your side to life. NGS and Precision Genetics: We are at the technical forefront of predictive and preventive medicine: we are always one step ahead, helping to diagnose it. Our Next Generation Sequencing (NGS) technology is the most advanced in the market, allowing for safer results, presenting them clearly and noticeably. We have the experience, know-how and professionalism you need to help you with accurate diagnosis.
11 to 50 staff
Innovplantprotect
We intend to develop innovative bio-based solutions to promote safer, more productive and more environmentally friendly agricultural crops.
11 to 50 staff
Portocanna
Founded in 2019, Portocanna is committed to delivering the best nature has to offer in an accessible, trustworthy, and consistent way. We believe that cannabis has arrived to disrupt the future of medicine and that it is only the first of many other potential plant-based disruptors. We aim to build a high-quality, valuable product portfolio and create a network of partnerships to release the best products in the market as branded products, or under partnerships with strategic distributors.
11 to 50 staff
Tec2med Summit
Welcome to the 1st World Tour of Tec2Med Academy, the Educational Branch of Tec2Med. Tec2Med is the portuguese brand pioneering the bridge between engineers, clinicians and scientists. From our congress, several ideas for projetcts and startups have born in the last 7 years. Without any support from political authorities until now, we have based on sponsorships and enthusiastic participants at events, helped curate more than 10 R&D projects and support educational events for more than people since 2019. Founded and still on building by young enterpreneurs and guided by out-of-the box researchers, our brand and Summit are now present in two continents, running everything through a non-profit organization. All the excellency you see here is made by hard working people seeking to make their community better. If you want to know us, collaborate, have an idea and want to implement it, or if you want to support our work, please contact us through tec2med2gmail.com. All our work serves de benefit of the patients and innovators. Our first educational World Tour is called: “Bridging Healing Innovation”! Join us on 15-19th October in Lisbon, Portugal and 19th September in San Paulo, Brazil! Stay tuned for more informations!
11 to 50 staff
Genet
GeneT | The Gene Therapy Centre of Excellence at the Center of Portugal
51 to 200 staff
Letra - Brewery
A Fermentum - Engenharia das Fermentações,Lda é uma Start-up portuguesa criada no contexto académico da Universidade do Minho. Actualmente sediada no centro de Vila Verde (Braga), a Fermentum detém, produz e comercializa a marca de cerveja artesanal "LETRA - Cerveja Artesanal Minhota", dedicando-se também à investigação no ramo cervejeiro, estabelecendo multiplas parcerias com entidades académicas. No momento a Fermentum é um dos maiores produtores de cerveja artesanal do país, tendo intenções de continuar a evoluir a nível técnico e crescer a nível de mercado, mantendo sempre a qualidade do trabalho e do produto assegurada.
11 to 50 staff
Phycoferm
We help to reduce food waste, by transforming agricultural surplus and byproducts into nutritious and delicious food. PhycoFerm was founded with a mission to transform food systems for people and the planet. We believe in regenerating ecosystems while producing high-quality nutrition, contributing to a sustainable future for all. Our microalgal fermentation technology uses industrial sidestreams to create sustainable proteins and bioactives, redefining how we approach food production. By recycling agricultural surplus and by-products into functional ingredients, we enable a regenerative bioeconomy while reducing waste and emissions. Our platform delivers diversified proteins, enriched with bioactives, that are scalable, cost-efficient, and eco-friendly. With applications ranging from food supplements to nutraceuticals, we want to contribute to a sustainable, circular economy. Join us in creating a regenerative food system for the planet and its people. First place in the 2024 Blue Bio Value Ideation program. First place in the 2025 Ideias em Caixa program.
1 to 10 staff
Ambifood
Bem-vindo/a ao LinkedIn da Ambifood! A nossa empresa fornece soluções para o controlo de qualidade nos ramos ambiental, industrial, alimentar e veterinária. Os nossos produtos têm um grande impacto na sua vida e nos bens que consome, desde o controlo de qualidade da água de consumo, à formulação da cor na roupa que usa ou no carro que conduz, passando pela análise de vinhos ou até mesmo kits de diagnóstico para controlo de doenças animais. Na nossa página do LinkedIn não vamos apenas apresentar-lhe produtos para que a sua vida profissional se torne mais fácil e económica; vamos também partilhar curiosidades e informações úteis para o seu dia-a-dia! Visite o nosso site e conheça todas as nossas soluções para si e para o seu negócio Econtre-nos no Facebook em
1 to 10 staff
Expresstec
ExpressTec is a biotech startup company founded by two women and a spin-off from the University of Algarve. Our vision is to provide patients with easy access to accurate personalized cancer therapy. To achieve this, we are developing RNA-based approaches to revolutionize clinical testing by accurately and efficiently selecting cancer patients for targeted therapies. Our innovative approach will help to optimize treatment outcomes, reduce side effects, and ultimately improve the quality of life for cancer patients. Join us on our mission to transform cancer care through cutting-edge technology and a commitment to patient-centred solutions. For more information, please visit our website at
1 to 10 staff
Rodon Biologics
Rodon Biologics is focusing in providing excellence in development of biopharmaceutical products for third parties. Over the last 20 years Rodon Biologics (previously as Biotecnol SA) has successfully completed numerous product and process development projects for different stages in the drug development cycle, from research to clinical trial Phase Partner led-programs have been undertaken on behalf of small, mid and large size biotechnology and also for large pharmaceutical companies. Product track record includes cytokines, growth factors, antibody fragments, immunotoxins, antibodies and multispecific antibody based formats. This continuous activity has resulted in accumulation of a significant know-how and experience with project management and a wide ranges of technologies for the development / optimization of processes and the manufacture of biological product molecules. Moreover, the intensive work on its own products pipeline also originated a new set of competencies i.e. bispecifics and highly specific analytical work. Rodon Biologics is customer-centric and innovative, in a way that customers receive products that better fit their needs, with a more complete offering in terms of services. So, in addition to full process development the new services matrix includes stand alone services (from the cloning and expression of the gene of interest, to the offering of milligrams of product for early testing, and pre-clinical toxicity batches for IND filling). Effective, robust, reliable and cost efficient manufacturing strategies are required to meet the rigorous demands of making biologics for human use. Companies need to consider their process development strategies very early in a product’s lifecycle - this is where Rodon Biologics provides an invaluable service.
11 to 50 staff
